A carregar...

Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues

Anti-angiogenic therapies are an important class of anti-cancer treatment drugs. However, their efficacy is limited to certain tumors and would benefit from identifying a biomarker predictive of therapeutic response. TP53 (tumor protein p53) is a tumor suppressor gene frequently mutated in cancer an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Ther
Main Authors: Li, Alex M., Boichard, Amélie, Kurzrock, Razelle
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012180/
https://ncbi.nlm.nih.gov/pubmed/31564192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1665956
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!